Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows-Reference-Cited by-同舟云学术

Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows

Published:2024-07-31 Issue:1 Volume:16 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Jain Tushar¹,Prinz Bianka²,Marker Alexander³,Michel Alexander⁴,Reichel Katrin⁵,Czepczor Valerie⁶,Klieber Sylvie⁶,Sun Wei⁴,Kathuria Sagar⁷,Oezguer Bruederle Sevim⁵,Lange Christian⁵,Wahl Lena⁵,Starr Charles⁸,Masiero Alessandro⁹,Avery Lindsay⁴

Affiliation:

1. Department of Computational Biology, Adimab LLC, Mountain View, CA, USA

2. Department of Antibody Discovery, Adimab LLC, Lebanon, NH, USA

3. Department of Drug Metabolism and Pharmacokinetics, Sanofi, Frankfurt, Germany

4. Department of Drug Metabolism and Pharmacokinetics, Sanofi, Cambridge, MA, USA

5. Department of Large Molecule Research, Sanofi, Frankfurt, Germany

6. Department of Drug Metabolism and Pharmacokinetics, Sanofi, Paris, France

7. Department of Large Molecule Research, Sanofi, Cambridge, MA, USA

8. Sanofi, Global CMC Development, Framingham, MA, USA

9. Department of Large Molecule Research, Sanofi, Paris, France

Publisher

Informa UK Limited